Compliance Rate

Compliance Rate 36.36%
Compliant submissions 8
Incompliant submissions 14
Total trials 22

My Organizations' Clinical Trials

Showing 1100 of 1641 entries
View as:

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone

Phase: N/A Priority: Normal
NCT ID: NCT02576912 Org: User:
Start: 02/28/15 End: 06/24/19 Due: 06/24/20

Relief of Symptoms of Post-traumatic Stress for Victims of Gun Violence

Phase: N/A Priority: Normal
NCT ID: NCT03916614 Org: User:
Start: 01/01/20 End: 01/01/22 Due: 01/01/23

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Phase: N/A Priority: Normal
NCT ID: NCT06209359 Org: User:
Start: 07/24/24 End: 03/01/28 Due: 03/01/29

Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries

Phase: N/A Priority: Normal
NCT ID: NCT02004561 Org: User:
Start: 01/31/12 End: 12/31/25 Due: 12/31/26

Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors

Phase: N/A Priority: Normal
NCT ID: NCT02008292 Org: User:
Start: 09/30/13 End: 12/31/21 Due: 12/31/22

Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms

Phase: N/A Priority: Normal
NCT ID: NCT05317481 Org: User:
Start: 04/01/22 End: 03/31/25 Due: 03/31/26

Nicotinic Receptor Augmentation of SSRI Antidepressants

Phase: N/A Priority: Normal
NCT ID: NCT00319319 Org: User:
Start: 01/31/03 End: 01/31/07 Due: 01/31/08

Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03582956 Org: User:
Start: 01/01/19 End: 08/12/22 Due: 08/12/23

A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06028932 Org: User:
Start: 01/08/24 End: 11/01/27 Due: 11/01/28

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Phase: N/A Priority: Normal
NCT ID: NCT04355572 Org: User:
Start: 07/31/25 End: 07/01/27 Due: 07/01/28

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Phase: N/A Priority: Normal
NCT ID: NCT04661072 Org: User:
Start: 07/14/21 End: 08/31/27 Due: 08/31/28

Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET

Phase: N/A Priority: Normal
NCT ID: NCT01719497 Org: User:
Start: 06/30/09 End: 05/31/14 Due: 05/31/15

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06521762 Org: User:
Start: 06/30/25 End: 12/31/28 Due: 12/31/29

Virtual Interactive Platform (VIP) Transplant Research Study

Phase: N/A Priority: Normal
NCT ID: NCT02828605 Org: User:
Start: 07/15/16 End: 12/30/16 Due: 12/30/17

Pain Care at Home to Amplify Function (Pain CHAMP)

Phase: N/A Priority: Normal
NCT ID: NCT05333341 Org: User:
Start: 06/16/23 End: 10/31/26 Due: 10/31/27

Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05223829 Org: User:
Start: 08/01/23 End: 08/30/25 Due: 08/30/26

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT02396979 Org: User:
Start: 01/31/10 End: 12/31/14 Due: 12/31/15

CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.

Phase: N/A Priority: Normal
NCT ID: NCT04109690 Org: User:
Start: 12/30/19 End: 07/27/21 Due: 07/27/22

Cortical GABA Concentrations in Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00765752 Org: User:
Start: 11/30/07 End: 06/30/11 Due: 06/30/12

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2

Phase: N/A Priority: Normal
NCT ID: NCT03168191 Org: User:
Start: 05/02/17 End: 02/25/19 Due: 02/25/20

The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge from Ambulatory Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05676294 Org: User:
Start: 06/26/23 End: 01/31/26 Due: 01/31/27

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

Phase: N/A Priority: Normal
NCT ID: NCT04131829 Org: User:
Start: 10/14/19 End: 12/31/25 Due: 12/31/26

Specialized Treatment Early in Psychosis (STEP)

Phase: N/A Priority: Normal
NCT ID: NCT00309452 Org: User:
Start: 03/31/06 End: 08/31/13 Due: 08/31/14

Standardized Field Test for Marijuana Impairment II

Phase: N/A Priority: Normal
NCT ID: NCT05115513 Org: User:
Start: 08/25/22 End: 12/31/25 Due: 12/31/26

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Phase: N/A Priority: Normal
NCT ID: NCT03356483 Org: User:
Start: 11/13/18 End: 07/25/24 Due: 07/25/25